Skip to main content
All lobbying filings

G2G CONSULTING

Lobbying for SHEPHERD THERAPEUTICS · rare cancer R&D

 Filing 1st Quarter - Report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 21, 2025
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
Massachusetts

Official filing document

 Lobbyists on this filing 3
  • ELIZABETH POWELL
    Previously held: Legislative Director for Rep. Jim Langevin 2001-2002 and Legislative Director for Rep. Juanita Millender-McDonald 1997-2001
  • KATHERINE M COLLINS
    Previously held: Deputy Director of Operations, The Executive Residence, Executive Office of the President (2011-2016) and Policy Associate, White House Cancer Moonshot Task Force, Office of the Vice President, Executive Office of the President (2016-2017)
  • CHRISTOPHER WILLIAM COOPER
    Previously held: Chief Appropriations Counsel,Chief of Staff,Legislative Director,Senior Legislative Assistant,Legislative Assistant for David Joyce (2013-2023) & Legislative Assistant/ Correspondent,Staff Assistant,Legislative Intern for Steven LaTourette(2011-2013)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 4
  • Centers For Medicare and Medicaid Services (CMS)
  • Health & Human Services, Dept of (HHS)
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 4
Budget/Appropriations

regarding funding and awareness of rare cancers

Health Issues

regarding funding and awareness of rare cancers

Defense

regarding funding and awareness of rare cancers

Veterans

regarding funding and awareness of rare cancers

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem